Apyx Medical Corp Accounts Receivable
Apyx Medical Corp (APYX) had Accounts Receivable of $13.61 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2026-08-06
- 2026-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $13.61M.
- 2026-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $12.76M.
- 2025-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $16.78M.
- 2025-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $12.99M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current | Accounts Receivable, after Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2026-06-30 | $13.61M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $12.76M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $16.78M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $12.99M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $11.25M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $11.64M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $15.48M 10-K · filed 2026-03-10 | |
| 2024-09-30 | $13.04M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $12.71M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $12.49M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $14.02M 10-K · filed 2025-03-13 | |
| 2023-09-30 | $12.65M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $12.07M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $9.97M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $10.60M 10-K · filed 2024-03-21 | |
| 2022-09-30 | $9.09M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $10.34M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $12.36M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $13.04M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $11.44M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $8.98M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $7.68M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $8.40M 10-K · filed 2022-03-17 | |
| 2020-09-30 | $6.15M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $6.31M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $6.12M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $7.99M 10-K · filed 2021-03-31 | |
| 2019-09-30 | $7.66M 10-Q · filed 2019-11-15 | |
| 2019-06-30 | $5.29M 10-K · filed 2020-03-31 | $6.22M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $4.97M 10-Q/A · filed 2020-05-08 | $4.93M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $5.08M 10-Q/A · filed 2020-05-08 | $5.01M 10-K · filed 2019-03-14 |
| 2018-09-30 | $4.14M 10-Q/A · filed 2020-05-08 | $4.08M 10-Q · filed 2018-11-02 |
| 2018-06-30 | $5.59M 10-Q · filed 2018-08-01 | |
| 2018-03-31 | $5.14M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $4.86M 10-Q/A · filed 2020-05-08 | |
| 2017-09-30 | $4.08M 10-Q · filed 2017-11-03 | |
| 2017-06-30 | $4.93M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $4.28M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $4.73M 10-K · filed 2018-03-13 | |
| 2016-09-30 | $3.87M 10-Q · filed 2016-10-27 | |
| 2016-06-30 | $3.51M 10-Q · filed 2016-08-02 | |
| 2016-03-31 | $3.14M 10-Q · filed 2016-05-11 | |
| 2015-12-31 | $2.92M 10-K · filed 2017-03-10 | |
| 2015-09-30 | $2.52M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $2.04M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $1.40M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $1.99M 10-K · filed 2016-03-18 | |
| 2014-09-30 | $2.04M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $2.62M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $2.23M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $1.99M 10-K · filed 2015-02-27 | |
| 2013-09-30 | $2.10M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $2.37M 10-Q/A · filed 2013-09-25 | |
| 2013-03-31 | $1.93M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $2.87M 10-K/A · filed 2014-05-08 | |
| 2012-09-30 | $2.64M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $2.63M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $2.56M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $2.22M 10-K · filed 2013-04-01 | |
| 2011-09-30 | $2.18M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $2.22M 10-Q · filed 2011-08-12 | |
| 2010-12-31 | $2.11M 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |